Key result
IFI-16 inhibition reduces inflammation, mitigates remodeling, and improves cardiac function post-MI.
Why the study?
Inflammation is key to cardiac remodeling following MI, but the specific involvement of the pattern recognition receptor IFI-16 remains underexplored.
Does suppression of IFI-16/IFI-204 reduce inflammatory factor activation and myocardial remodeling in preclinical models of myocardial infarction?
Does suppression of IFI-16/IFI-204 reduce inflammatory factor activation and myocardial remodeling in preclinical models of myocardial infarction?
Inhibition of IFI-16 attenuates post-MI myocardial remodeling and inflammation in preclinical models, suggesting a potential novel therapeutic target for preventing heart failure.
Rodent data only; leaves open IFI-16 inhibition as a human post-MI target.
Myocardial remodeling (MR) following myocardial infarction (MI) contributes to heart failure. Inflammation is a key determinant in cardiac remodeling, with potential prognostic improvements by inhibiting inflammatory factors. Pattern recognition receptors, including interferon gamma-inducible protein-16 (IFI-16), play significant roles in this process, yet its specific involvement remains underexplored. This study investigates IFI-16’s role in initiating inflammation via the inflammasome and its direct interaction with galectin-3 protein post-MI. Elevated IFI-16 levels were observed in human and rat myocytes and a mouse MI model under hypoxic, nutrient-deprived conditions, correlating with increased inflammation-associated proteins. Suppression of IFI-16/IFI-204 using short hairpin RNA (shRNA) lentivirus or adeno-associated virus decreased inflammatory factor activation, thereby mitigating remodeling and enhancing cardiac function post-MI. Co-immunoprecipitation (coIP) and double-fluorescence staining confirmed IFI-16’s ability to interact directly with galectin-3. These findings underscore IFI-16’s critical role as a pro-inflammatory factor in post-MI MR, suggesting its inhibition as a potential therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2024) studied Myocardial remodeling following myocardial infarction. IFI-16/IFI-204 suppression (shRNA lentivirus or AAV) was evaluated on Inflammatory factor activation, myocardial remodeling, and cardiac function. Inhibition of IFI-16 using shRNA lentivirus or adeno-associated virus decreased inflammatory activation, mitigated myocardial remodeling, and enhanced cardiac function post-myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: